Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anorexia Nervosa with Significantly Low Body Weight × Olanzapine × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Nausea 5 Vomiting 4 Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Weight Loss 1 Stomach Neoplasms 1 Radiation Injuries 1 Neoplasms, Germ Cell and Embryonal 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Cachexia 1 Breast Neoplasms 1 Anorexia Nervosa with Significantly Low Body Weight 1 Anorexia 1

Interventions

Olanzapine 1 Mirtazapine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170919 2024-09-19

Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer

Englewood Hospital and Medical Center

Phase 2 Enrolling by invitation

Anorexia Nervosa with Significantly Low Body Weight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡